News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
588,340 Results
Type
Article (19826)
Company Profile (173)
Press Release (568411)
Multimedia
Podcasts (80)
Webinars (13)
Section
Business (200013)
Career Advice (727)
Deals (30996)
Drug Delivery (87)
Drug Development (66534)
Employer Resources (58)
FDA (12633)
Job Trends (11380)
News (290743)
Policy (24455)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (923)
Accelerated approval (41)
ADA (27)
Adcomms (10)
Allergies (145)
Alliances (42317)
ALS (144)
Alzheimer's disease (1304)
Antibody-drug conjugate (ADC) (362)
Approvals (13266)
Artificial intelligence (514)
ASCO (225)
Autoimmune disease (267)
Automation (41)
Bankruptcy (320)
Best Places to Work (8639)
BIO (47)
BIOSECURE Act (11)
Biosimilars (202)
BioSpace Insights (76)
Biotechnology (107)
Bladder cancer (158)
Brain cancer (56)
Breast cancer (609)
Cancer (4566)
Cardiovascular disease (361)
Career advice (629)
Career pathing (15)
CAR-T (223)
CDC (9)
Celiac Disease (1)
Cell therapy (627)
Cervical cancer (43)
Clinical research (59623)
Collaboration (1743)
Commercialization (3)
Company closure (1)
Compensation (1450)
Complete response letters (62)
COVID-19 (1334)
CRISPR (84)
C-suite (1045)
Cystic fibrosis (131)
Data (6753)
Decentralized trials (1)
Denatured (23)
Depression (130)
Dermatology (73)
Diabetes (453)
Diagnostics (4919)
Digital health (45)
Diversity (3)
Diversity, equity & inclusion (18)
Drug discovery (272)
Drug pricing (127)
Drug shortages (15)
Duchenne muscular dystrophy (233)
Earnings (81449)
Editorial (26)
Employer branding (6)
Employer resources (54)
Events (100269)
Executive appointments (965)
FDA (15835)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (21)
Frontotemporal dementia (27)
Funding (1254)
Gene editing (168)
Generative AI (35)
Gene therapy (474)
GLP-1 (681)
Government (2078)
Grass and pollen (6)
Guidances (343)
Healthcare (11552)
Hematology (133)
HIV (56)
Huntington's disease (29)
IgA nephropathy (100)
Immunology and inflammation (174)
Immuno-oncology (77)
Indications (197)
Infectious disease (1580)
Inflammatory bowel disease (175)
Inflation Reduction Act (10)
Influenza (104)
Intellectual property (294)
Interviews (98)
IPO (14058)
IRA (33)
Job creations (3125)
Job search strategy (570)
JPM (29)
Kidney cancer (20)
Labor market (39)
Layoffs (258)
Leadership (11)
Legal (6619)
Licensing (6)
Liver cancer (55)
Longevity (21)
Lung cancer (649)
Lymphoma (353)
Machine learning (35)
Management (20)
Manufacturing (908)
Marketing (11)
MASH (167)
Medical affairs (1)
Medical device (9423)
Medtech (9571)
Mergers & acquisitions (18121)
Metabolic disorders (1090)
mRNA (110)
Multiple sclerosis (147)
NASH (16)
Neurodegenerative disease (305)
Neuropsychiatric disorders (73)
Neuroscience (2498)
Neurotech (1)
NextGen: Class of 2026 (4018)
Non-profit (1418)
Now hiring (23)
Obesity (435)
Opinion (160)
Ovarian cancer (175)
Pain (243)
Pancreatic cancer (227)
Parkinson's disease (286)
Partnered (20)
Patents (574)
Patient recruitment (606)
Peanut (39)
People (51079)
Pharmaceutical (46)
Pharmacy benefit managers (23)
Phase 1 (18364)
Phase 2 (26229)
Phase 3 (19477)
Pipeline (8600)
Policy (168)
Postmarket research (2146)
Preclinical (7667)
Press Release (52)
Prostate cancer (243)
Psychedelics (31)
Radiopharmaceuticals (272)
Rare diseases (874)
Real estate (4530)
Recruiting (21)
Regulatory (19994)
Reports (23)
Research institute (1031)
Resumes & cover letters (96)
Rett syndrome (43)
RNA editing (12)
RSV (54)
Schizophrenia (151)
Series A (227)
Series B (160)
Service/supplier (5)
Sickle cell disease (98)
Special edition (11)
Spinal muscular atrophy (125)
Sponsored (17)
Startups (2837)
State (2)
Stomach cancer (8)
Supply chain (96)
Tariffs (71)
The Weekly (55)
Vaccines (535)
Venture capital (56)
Weight loss (232)
Women's health (100)
Worklife (4)
Date
Today (102)
Last 7 days (590)
Last 30 days (1799)
Last 365 days (23672)
2026 (14470)
2025 (23675)
2024 (27649)
2023 (31829)
2022 (41330)
2021 (43945)
2020 (40557)
2019 (30597)
2018 (23212)
2017 (25038)
2016 (23939)
2015 (29801)
2014 (25960)
2013 (22364)
2012 (24362)
2011 (24667)
2010 (23820)
Location
Africa (484)
Alabama (81)
Alaska (2)
Arizona (333)
Arkansas (13)
Asia (30753)
Australia (4249)
California (12573)
Canada (3438)
China (1068)
Colorado (507)
Connecticut (465)
Delaware (279)
Europe (56176)
Florida (1919)
Georgia (401)
Hawaii (3)
Idaho (49)
Illinois (901)
India (94)
Indiana (558)
Iowa (15)
Japan (562)
Kansas (117)
Kentucky (37)
Louisiana (31)
Maine (27)
Maryland (1354)
Massachusetts (8660)
Michigan (324)
Minnesota (600)
Mississippi (5)
Missouri (106)
Montana (27)
Nebraska (16)
Nevada (116)
New Hampshire (68)
New Jersey (3208)
New Mexico (19)
New York (3102)
North Carolina (1503)
North Dakota (4)
Northern California (6293)
Ohio (307)
Oklahoma (16)
Oregon (29)
Pennsylvania (2399)
Puerto Rico (27)
Rhode Island (36)
South America (750)
South Carolina (79)
South Dakota (1)
Southern California (5163)
Tennessee (147)
Texas (2018)
United States (42737)
Utah (384)
Vermont (1)
Virginia (263)
Washington D.C. (55)
Washington State (980)
West Virginia (2)
Wisconsin (104)
Wyoming (1)
588,340 Results for "spectrum pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Model Medicines to Present New Data on MDL-001 at ASV 2026: Broad-Spectrum Antiviral Activity Across Six Viral Families
Oral presentation unifies the respiratory and hepatic programs. The first-in-class, direct-acting, broad-spectrum, Thumb-1 polymerase inhibitor demonstrates single-agent activity against influenza, RSV, SARS-CoV-2, HCV, HBV, and HDV, including activity against oseltamivir-resistant influenza and oral in vivo proof-of-concept.
July 23, 2026
·
1 min read
Press Releases
Astrogen Inc. Receives 18th Folia Award for Outstanding Clinical Research in Autism Spectrum Disorder
June 19, 2026
·
2 min read
Press Releases
Spectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation Technology
June 11, 2026
·
3 min read
Press Releases
MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder
June 22, 2026
·
8 min read
Press Releases
Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy
May 20, 2026
·
5 min read
Press Releases
Battelle’s RavenStar™ Ultra-Wideband Massive MIMO Radio Unit Awarded Contract to Advance Spectrum Sharing Technology
June 9, 2026
·
3 min read
Press Releases
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
August 5, 2026
·
3 min read
Press Releases
Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
May 18, 2026
·
10 min read
Press Releases
Nuvation Bio Announces Positive Updated Phase 2 Data and Expansion of Safusidenib Clinical Program with Two New Studies to Explore Broad Spectrum of IDH1-Mutant Glioma
July 20, 2026
·
9 min read
Press Releases
Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
May 11, 2026
·
10 min read
1 of 58,834
Next
